IGC Pharma, Inc. (NASDAQ:IGC) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
IGC Pharma, Inc.

BRIEF

published on 01/28/2025 at 14:35, 10 months 7 days ago

IGC Pharma Emerges as Top 15 Finalist in Alzheimer's Detection Challenge

AI Innovation Healthcare Technology IGC Pharma PREPARE Challenge Alzheimer's Detection
PRESS RELEASE

published on 01/28/2025 at 14:30, 10 months 7 days ago

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease
IGC Pharma selected as top 15 finalist in NIA's PREPARE Challenge Phase 2 for using AI in early Alzheimer's detection. CEO highlights company's innovative approach to improve patient outcomes and address disparities

AI IGC Pharma PREPARE Challenge Alzheimer's Detection NIA
BRIEF

published on 01/21/2025 at 14:35, 10 months 14 days ago

Former Virginia Governor Terry McAuliffe Joins IGC Pharma as Strategic Advisor

Strategic Partnerships IGC Pharma Terry McAuliffe Alzheimer's Care Biotechnology Growth
PRESS RELEASE

published on 01/21/2025 at 14:30, 10 months 14 days ago

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor
IGC Pharma, Inc. appoints Terry McAuliffe, 72nd Governor of Virginia, as strategic advisor to advance Alzheimer's care and growth in biotech and pharma sectors

Pharmaceutical Industry Biotechnology IGC Pharma Terry McAuliffe Alzheimer's Care
BRIEF

published on 01/13/2025 at 14:35, 10 months 22 days ago

IGC Pharma to Engage in Strategic Discussion with Ascendiant Capital Markets

Fireside Chat Metabolic Disorders AI In Drug Discovery IGC Pharma Alzheimer's Pipeline
PRESS RELEASE

published on 01/13/2025 at 14:30, 10 months 22 days ago

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
IGC Pharma, Inc. to participate in a fireside chat hosted by Ascendiant Capital Markets to discuss recent progress, including advancements in Alzheimer's pipeline and expansion into metabolic disorders

Fireside Chat Metabolic Disorders IGC Pharma Alzheimer's Pipeline Ascendiant Capital Markets
BRIEF

published on 01/08/2025 at 14:35, 10 months 27 days ago

IGC Pharma Expands CALMA Trial Recruitment for Alzheimer's Agitation

Clinical Trial IGC Pharma CALMA Trial Alzheimer's Agitation Geofencing Technology
PRESS RELEASE

published on 01/08/2025 at 14:30, 10 months 27 days ago

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy
IGC Pharma, Inc. leverages geofencing technology to boost enrollment for Phase 2 CALMA trial addressing agitation in Alzheimer's disease. Advanced outreach tools enhance patient and caregiver engagement

Alzheimer's Disease IGC Pharma CALMA Trial Geofencing Technology Enrollment Boost
BRIEF

published on 12/20/2024 at 01:05, 11 months 16 days ago

IGC Pharma to Engage in BIO Partnering @ JPM with Key Stakeholders

Healthcare Strategy IGC Pharma BIO Partnering JPM Conference Pharmaceutical Meetings
PRESS RELEASE

published on 12/20/2024 at 01:00, 11 months 16 days ago

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025
IGC Pharma, Inc. will participate in BIO Partnering @ JPM alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025. The management team will showcase recent partnerships and achievements

Clinical-stage Biotechnology IGC Pharma Alzheimer's Treatment J.P. Morgan Healthcare Conference BIO Partnering @ JPM

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 38 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE